Current Drug Targets
Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Ranking and Category
-
131st of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Targets, Volume 10 - Number 2
Editorial [Hot Topic: The Fabisch-Symposium 2009 on Targeted Tumor Therapies(Guest Editors: C. Bachran and H. Fuchs)]
, 10(2): 88Christopher Bachran and Hendrik Fuchs
DOI: 10.2174/138945009787354548
Targeted Tumor Therapies at a Glance
, 10(2): 89 - 93H. Fuchs and C. Bachran
DOI: 10.2174/138945009787354557
Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family
, 10(2): 94 - 103E. Bremer, M. de Bruyn, H. Wajant and W. Helfrich
DOI: 10.2174/138945009787354593
Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma
, 10(2): 104 - 109A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville and J. H. Woo
DOI: 10.2174/138945009787354539
Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
, 10(2): 110 - 117B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop
DOI: 10.2174/138945009787354566
Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
, 10(2): 118 - 125U. Elsasser-Beile, P. Buhler and P. Wolf
DOI: 10.2174/138945009787354601
Saponins as Tool for Improved Targeted Tumor Therapies
, 10(2): 140 - 151H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland and C. Bachran
DOI: 10.2174/138945009787354584
  |
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net